-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Emergent BioSolutions Inc. quarterly/annual Depreciation history and growth rate from 2019 to Q3 2025.
- Emergent BioSolutions Inc. Depreciation for the quarter ending September 30, 2025 was $7.1M, a 29.7% decline year-over-year.
- Emergent BioSolutions Inc. Depreciation for the twelve months ending September 30, 2025 was $33.2M, a 30% decline year-over-year.
- Emergent BioSolutions Inc. annual Depreciation for 2024 was $43.7M, a 26.6% decline from 2023.
- Emergent BioSolutions Inc. annual Depreciation for 2023 was $59.5M, a 28.7% decline from 2022.
- Emergent BioSolutions Inc. annual Depreciation for 2022 was $83.4M, a 34.1% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)